Stay updated on Sovaldi® Plus Copegus® in Genotype 2 Hep C Clinical Trial

Sign up to get notified when there's something new on the Sovaldi® Plus Copegus® in Genotype 2 Hep C Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Sovaldi® Plus Copegus® in Genotype 2 Hep C Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    Change Detected
    Summary
    The study record for the post-marketing surveillance study of Sovaldi plus Copegus in Japanese patients with genotype 2 hepatitis C is displayed, with its study details and locations.
    Difference
    46%
    Check dated 2026-11-09T14:52:02.000Z thumbnail image
  3. Check
    17 days ago
    Change Detected
    Summary
    The footer revision label changed from v3.7.2 to v3.8.0.
    Difference
    0.2%
    Check dated 2026-11-02T16:24:06.000Z thumbnail image
  4. Check
    24 days ago
    Change Detected
    Summary
    A banner announces an NIH website transition and says federal agencies are using “Super Intelligence” (SI) in place of “Artificial Intelligence” (AI), with updates and FAQs available.
    Difference
    1%
    Check dated 2026-10-26T15:13:58.000Z thumbnail image
  5. Check
    31 days ago
    Change Detected
    Summary
    The site revision identifier in the footer changed from v3.7.1 to v3.7.2 on the 403 error page.
    Difference
    0.2%
    Check dated 2026-10-19T14:44:29.000Z thumbnail image
  6. Check
    38 days ago
    Change Detected
    Summary
    The footer revision label changed from v3.7.0 to v3.7.1 while the study page continued to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-12T15:55:44.000Z thumbnail image
  7. Check
    58 days ago
    Change Detected
    Summary
    The study page now shows a 403 Forbidden error instead of the study details, with the standard site header and footer visible, indicating restricted access.
    Difference
    14%
    Check dated 2026-09-21T22:10:13.000Z thumbnail image

Stay in the know with updates to Sovaldi® Plus Copegus® in Genotype 2 Hep C Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Sovaldi® Plus Copegus® in Genotype 2 Hep C Clinical Trial page.